BGC Group, Inc. today reported its financial results for the fourth quarter and full year ended December 31, 2024. A complete financial results press release, including information about today's ...
Global biotechnology leader CSL and sa-mRNA pioneer Arcturus Therapeutics today announced that the European Commission has granted marketing authorization for KOSTAIVE® (ARCT-154), a self-amplifying ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback